BIOLEGEND ELIMINATES FEEDER CELLS FROM NK CELL MANUFACTURING WITH NEW CELL-VIVE ACTIVATION BEADS
September 17, 2025
Natural killer (NK) cells are emerging as a transformative force in cancer immunotherapy, offering unique advantages including innate tumor recognition, potent cytotoxicity, and the potential for off-the-shelf therapeutic applications. However,...
Learn more